Renaissance Capital LLC Acquires 351,259 Shares of Kenvue Inc. $KVUE

Renaissance Capital LLC boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 55.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 980,436 shares of the company’s stock after acquiring an additional 351,259 shares during the period. Kenvue accounts for 8.9% of Renaissance Capital LLC’s holdings, making the stock its 2nd biggest position. Renaissance Capital LLC owned about 0.05% of Kenvue worth $15,912,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in shares of Kenvue by 1.8% in the second quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock valued at $4,881,844,000 after purchasing an additional 4,101,880 shares during the period. Geode Capital Management LLC grew its stake in Kenvue by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 49,001,887 shares of the company’s stock valued at $1,021,267,000 after buying an additional 604,953 shares during the last quarter. Independent Franchise Partners LLP grew its stake in Kenvue by 233.4% in the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock valued at $654,388,000 after buying an additional 21,886,537 shares during the last quarter. American Century Companies Inc. raised its holdings in Kenvue by 38.6% in the 2nd quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock valued at $633,447,000 after acquiring an additional 8,436,166 shares during the period. Finally, Norges Bank acquired a new stake in Kenvue during the second quarter worth approximately $537,418,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on KVUE. Redburn Partners set a $22.00 target price on Kenvue in a research report on Friday, September 26th. Evercore ISI set a $18.00 price objective on Kenvue in a report on Tuesday, October 28th. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. UBS Group reduced their target price on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group reaffirmed a “hold” rating and set a $15.00 price target (down from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, Kenvue currently has an average rating of “Hold” and an average price target of $20.23.

Insider Buying and Selling at Kenvue

In other news, Director Jeffrey C. Smith purchased 3,200,000 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was bought at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the acquisition, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.17% of the company’s stock.

Kenvue Stock Performance

NYSE:KVUE opened at $17.33 on Wednesday. The company has a market cap of $33.20 billion, a price-to-earnings ratio of 23.11 and a beta of 0.60. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The stock has a fifty day moving average price of $16.53 and a 200-day moving average price of $18.63.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same quarter last year, the business earned $0.28 earnings per share. Kenvue’s revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a $0.2075 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. Kenvue’s payout ratio is presently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.